ISMP (US) Contact Us Feedback

Ongoing Collaborations

The Canadian Patient Safety Institute
An independent not-for-profit corporation, CPSI performs a coordinating and leadership role across health sectors and systems, promotes effective strategies and leading practices to improve patient safety, and raises awareness with stakeholders, patients and the general public about patient safety. CPSI has a national mandate to build and advance a safer health system for Canadians. The Institute provides leadership on patient safety issues, and helps to create a culture that is open to disclosure and committed to change that will improve care. By supporting healthcare professionals in their development and implementation of patient safety programs, such as Safer Healthcare Now! CPSI helps promote innovative and successful evidence-based strategies for improving patient safety. In addition to supporting and working with several Canadian health organizations on patient safety initiatives, CPSI has established a funding environment for research and analysis that encourages the exploration, exposure and resolution of patient safety issues.
The Institute for Safe Medication Practices of
Huntingdon Valley, PA (ISMP)
ISMP Canada is a partner of ISMP in the US; a representative of ISMP will serve as a trustee. ISMP has agreed to provide a full range of logistic and resource support to ISMP Canada, including use of material published in the ISMP Medication Safety Alert!, a biweekly email and fax alert publication sent to all US hospitals. ISMP has pledged use of their database of published events and recommendations, and will provide consultative support and tools already developed by ISMP for use in error prevention. A contractual agreement has been developed to outline the working relationship between these two organizations.
Health Canada

The Canadian Medication Incident Reporting and Prevention System (CMIRPS) has been developed through the collaborative efforts of Health Canada, the Institute for Safe Medication Practices Canada (ISMP Canada) and the Canadian Institute for Health Information (CIHI), with input from stakeholders across Canada. Discussions continue with the Canadian Patient Safety Institute to help ensure that CMIRPS is coordinated with other patient safety initiatives.

The aim of CMIRPS is to strengthen Canada's capacity to reduce and prevent harmful medication incidents and to manage and share information about voluntarily reported medication incidents. CMIRPS is designed to complement Health Canada's postmarket surveillance program, the Canadian Adverse Drug Reaction Monitoring Program. The Health Product InfoWatch (InfoWatch) [previously known as the Canadian Adverse Reaction Newsletter (CARN)] informs health care professionals of new safety information detected through the review of adverse reaction reports submitted to Health Canada. Visit the MedEffectTM Canada web site at to view or to subscribe for free to the InfoWatch.

Canadian Standards Association International
ISMP Canada will form a partnership with Canadian Standards Association International (CSA) to share ideas and data regarding medication errors, especially those involving drug names, packaging, containers and labels. ISMP Canada will provide input into development of standards for medical devices, drug containers, packaging and labels as required.
Canadian Association of Provincial Cancer Agencies (CAPCA)
ISMP Canada is a member of the Systemic Therapy Safety Council. ISMP Canada has also provided input and review to the Cancer Care Ontario (CCO) Systemic Treatment Computerized Prescriber Order Entry (ST CPOE) Guidelines.
Professional Organizations
ISMP Canada is a multidisciplinary nonprofit organization promoting patient safety through the reduction of error-induced injury. On a professional level, ISMP Canada has been successful in seeking formal collaboration and support from the Canadian Pharmacists Association, the Canadian Society of Hospital Pharmacists and the Canadian Nurses Association. An effort is underway to link with the Canadian Medical Association and the Royal College of Physicians and Surgeons of Canada.
Canadian Society of Hospital Pharmacists (CSHP)
The Canadian Society of Hospital Pharmacists and ISMP Canada have signed a Memorandum of Understanding to formally recognize their close working relationship and their mutual commitment to collaborate for the advancement of patient safety. CSHP has a lengthy history of leadership in the advancement of safe medication practices, including the promotion of safe drug distribution systems, the advancement of pharmacists' involvement in direct patient care and the active membership in the Canadian Coalition on Medication Incident Reporting and Prevention. CSHP has also played a major role in the development of standards for drug labelling and packaging. The development of the Canadian Medication Incident Reporting and Prevention System (CMIRPS) places ISMP Canada is in a unique position to assume a lead in the area of enhanced drug labelling and packaging. This will allow CSHP to concentrate on the direct patient care role of hospital pharmacists - a key component in patient safety.
ISMP Canada is in the process of establishing partnership with HealthCareCAN. Collaborative efforts include HealthCareCAN disseminating information for ISMP Canada, facilitating and fostering ISMP Canada's working relationship with the provincial hospital associations. HealthCareCAN will also consider participating in other initiatives and projects that help Canadian healthcare institutions to implement strategies to prevent or reduce injuries to patients due to medication use.
Canadian Nurses Association
ISMP Canada has formed a partnership with the Canadian Nurses Association. In addition to the web site links of the two organizations, CNA will promote ISMP Canada's safe medication practices philosophy to its members. CNA will also consider having an ISMP Canada column printed in one of their publications.
Ontario Hospital Association (OHA)
ISMP Canada has established a working relationship with the Ontario Hospital Association, the largest hospital association in Canada. Similar to CHA, OHA will disseminate important initiatives information to Ontario hospitals, and will organize joint educational workshops and sessions on safe medication practices. ISMP Canada will have a continuing dialogue with OHA to develop tools and strategies on implementing safe medication practice initiatives for hospitals in Ontario.
Healthcare Insurance Reciprocal of Canada (HIROC)
Healthcare Insurance Reciprocal of Canada (HIROC) is the largest healthcare liability insurer in Canada. HIROC's member-owners (Subscribers) include hospitals, nursing homes, community health centres, community care access centres and other health-related organizations. HIROC is committed to maximize the quality of healthcare delivery in Canada, and works proactively with its Subscribers to prevent error and reduce claims. ISMP Canada has a working relationship with HIROC, who shares ISMP Canada's philosophy and vision of patient safety and sponsors the ISMP Canada Safety Bulletin.
Canadian Addison Society
A registered National charity organization, the Canadian Addison Society provides support to people with Addison's Disease and Secondary Adrenal Insufficiency (SAI), and their families. The association seeks to educate the public and medical professionals by providing information regarding aspects of the disease. The Society connects those newly diagnosed with Addison's and SAI with education, support groups, and the opportunity to network with experienced peers. After having the privilege to speak at a support group meeting, ISMP Canada and the Canadian Addison Society will continue to work together to promote safe medication use for those with Addison's and SAI.
Other Organizations
ISMP Canada will explore an ongoing working relationship with the pharmaceutical industry and the Canadian Institute of Health Information. It will also form a working relationship with the National Patient Safety Foundation founded by the American Medical Association.
Representation by the Public (Patients)
A lay person representative of the public will be a member of the Board of Trustees.